The startup develops a medical drug that utilizes a modified tetanus toxin to increase muscle impulse rates, effectively tightening muscles. This treatment addresses disorders related to hypotonia, including sleep apnea and muscle recovery post-injury, providing long-lasting therapeutic benefits.
Funding
$1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Conditions characterized by hypotonia, such as sleep apnea, muscle weakness, and sphincter incontinence, lack effective and long-lasting therapeutic options. Current treatments often fail to provide sufficient muscle toning or require frequent administration to maintain efficacy. Brachycephalic Obstructive Airways Syndrome (BOAS) in animals also presents a significant challenge due to the limited availability of targeted pharmacological interventions.
Solution
Snoretox is developing a novel biotherapeutic based on modified tetanus toxin molecules designed to increase muscle impulse rates and provide long-lasting muscle toning. The company's patented technology modifies tetanus toxin to work safely alongside the tetanus vaccine, delivering targeted muscle strengthening effects. Snoretox therapeutics, including Snoretox™ for sleep apnea and Tonetox™ for other applications, aim to address a range of conditions associated with muscle weakness, offering potential improvements in breathing, muscle recovery, and sphincter control. The platform is being developed for both human and veterinary applications.
Target Audience
The primary target audience includes individuals suffering from conditions related to muscle weakness, such as sleep apnea and incontinence, as well as veterinarians treating animals with BOAS and related conditions.
Features
- Utilizes a modified tetanus toxin to enhance muscle tone and strength.
- Designed to work effectively without interference from the tetanus vaccine.
- Potential applications include treatment of BOAS in animals, sleep apnea, muscle recovery, and sphincter weakness (anal, oesophageal, bladder, pelvic floor).
- Being explored for neurological applications such as Multiple Sclerosis, Motor Neuron Disease, and Myopathy.
- Investigated for cosmetic muscle toning applications, including eyelid issues, facial and chin lifting.
- Trademarked therapeutics: Snoretox™ for sleep apnea and Tonetox™ for other applications.